# Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks

> **NCT00710827** · PHASE4 · WITHDRAWN · sponsor: **Bayer**

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** NEBIDO
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT00710827
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-10
- **Primary completion:** —
- **Final completion:** 2008-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00710827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00710827, "Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00710827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*